CAS 313348-27-5: Regadenoson
Description:Regadenoson is a pharmacological agent primarily used as a coronary vasodilator in medical imaging, particularly in stress testing for patients unable to undergo traditional exercise-based stress tests. It is a selective adenosine A2A receptor agonist, which means it binds to and activates these specific receptors, leading to vasodilation and increased blood flow in the coronary arteries. Regadenoson is characterized by its rapid onset of action and a relatively short half-life, making it suitable for use in clinical settings where quick diagnostic results are needed. The substance is typically administered intravenously and is known for its favorable safety profile, with fewer side effects compared to other stress agents. Its chemical structure includes a purine base, which is a common feature among adenosine derivatives. Regadenoson is marketed under various brand names and is an important tool in non-invasive cardiology for assessing myocardial perfusion.
Formula:C15H18N8O5
InChI:InChI=1S/C15H18N8O5/c1-17-13(27)6-2-19-23(3-6)15-20-11(16)8-12(21-15)22(5-18-8)14-10(26)9(25)7(4-24)28-14/h2-3,5,7,9-10,14,24-26H,4H2,1H3,(H,17,27)(H2,16,20,21)/t7-,9-,10-,14-/m1/s1
InChI key:InChIKey=LZPZPHGJDAGEJZ-AKAIJSEGSA-N
SMILES:O=C(NC)C=1C=NN(C1)C=2N=C(N)C=3N=CN(C3N2)C4OC(CO)C(O)C4O
- Synonyms:
- 2-[4-(methylcarbamoyl)-1H-pyrazol-1-yl]adenosine
- 2-[4-[(Methylamino)carbonyl]-1H-pyrazol-1-yl]adenosine
- 6-Amino-2-[4-(methylcarbamoyl)-1H-pyrazol-1-yl]purine-9-yl-beta-D-ribofuranoside
- Adenosine, 2-[4-[(methylamino)carbonyl]-1H-pyrazol-1-yl]-
- Cv 3146
- Cvt-3146
- Lexiscan
- Nqz-021
- Rapiscan
- Regadenoson
- See more synonyms
